Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price Falls 3.76%: What Today’s Decline Shows

Alkem Laboratories Ltd. fell to Rs 5215, down 3.76% today, with market capitalisation at Rs 65,402.06 crore.

Alkem Laboratories Share Price came under pressure on 14 August 2026, with the stock trading at Rs 5215 at the time of the data snapshot, down Rs 203.75 or 3.76% from the previous close of Rs 5418.75. The company’s market capitalisation stood at Rs 65,402.06 crore, making this a notable move in a large-cap name within the Healthcare space. In Stock Market Today conversations, that combination of size and decline is enough to put the stock on the radar as a top decliner and one of the Stocks in News.

The verified data confirms the price event clearly: Alkem Laboratories Share Price Today opened at Rs 5554.9, also the session high, before sliding to an intraday low of Rs 5207.5. That pattern points to early strength fading into sustained selling pressure through the day. The supplied data confirms the share price decline, but it does not establish a company-specific catalyst behind the move. That distinction matters because price action alone can show intensity without proving a reason.

For investors tracking Alkem Laboratories Stock News, the immediate takeaways are the depth of the intraday reversal, the gap between the open and the current price, and the stock’s relevance as a large-cap mover in the Indian Stock Market. Important numbers to monitor next include whether Alkem Laboratories Share Price holds near the day low, how total traded volume of 3,49,297 shares develops, and how this move compares with the broader Healthcare sector snapshot and listed peers. Univest is tracking the move through price, market cap and comparative sector data.

Alkem Laboratories Ltd. (ALKEM) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 5,215
Previous Close	Rs 5,418.75
Today's Change	Rs -203.75 (-3.76%)
Day Open	Rs 5,554.9
Day High	Rs 5,554.9
Day Low	Rs 5,207.5
Current Volume (BSE)	8,876
BSE Traded Volume	8,876
NSE Traded Volume	3,40,421
Combined NSE + BSE Volume	3,49,297
Turnover	Rs 4.63 crore
Market Capitalisation	Rs 65,402.06 crore
Market Cap Category	Large Cap

Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,215. versus the previous close of Rs 5,418.75, a fall of 3.76%. The stock opened at Rs 5,554.9, reached Rs 5,554.9, touched Rs 5,207.5. Reported volume was 8,876.

Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 65,402.06 crore

Alkem Laboratories Fundamental Analysis, based on the supplied data, begins with scale. A market capitalisation of Rs 65,402.06 crore places the company in the large-cap bracket, which matters because single-day price falls in companies of this size often attract wider attention than similar moves in smaller names. Market capitalisation, however, indicates company size rather than underlying quality, so it should be used as context rather than a verdict.

The current data set does not supply valuation multiples such as P/E Ratio, P/B Ratio or EV/EBITDA for Alkem Laboratories, nor does it provide profitability ratios like ROE or ROCE for the company itself. What it does provide is enough to frame today’s move as a market event with scale. A Rs 203.75 fall in a stock priced at Rs 5215 is a meaningful absolute move, while the 3.76% decline is material in percentage terms for a company with a market cap above Rs 65,000 crore.

For readers following Alkem Laboratories Stock Analysis and Alkem Laboratories Company News, turnover and volume add another layer to the fundamental context of the day’s trading. BSE turnover of Rs 4.63 crore and total volume of 3,49,297 shares suggest this was an actively watched session rather than an isolated print. In Share Market Today discussions, large-cap Healthcare names are often judged first by liquidity, price discipline and relative standing in the sector before deeper quarterly or annual company financials are reviewed.

The most useful way to read today’s decline, therefore, is as a verified price event in a large and liquid listed company rather than as proof of any fresh fundamental change. Alkem Laboratories Share Price is being watched because of the size of the move, the large-cap status of the stock and the way the session evolved from the open. That naturally leads to shareholding context where available, and then to sector and peer positioning, where the supplied dataset is stronger. Univest treats that distinction carefully: price action can be confirmed immediately, while business-quality conclusions require their own dedicated inputs.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.2x
Benchmark Average P/E	75.33x
Benchmark P/E Range	3.29x to 3,299.57x
Benchmark Median P/B	1.96x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 65,402.06 crore
Benchmark Median Market Cap	Rs 141.55 crore

Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The sector snapshot places Alkem Laboratories in Healthcare, and that context is useful because today’s share price decline happened in a company with a market value far larger than the benchmark distribution supplied for the same sector. Sector comparisons do not explain the fall by themselves, but they help investors judge relative scale and valuation background.

The benchmark scope covers 196 companies in the same sector. Within that universe, the median market capitalisation is Rs 141.55 crore and the average is Rs 465.17 crore, with a minimum of Rs 3.67 crore and a maximum of Rs 2995.34 crore. Against that backdrop, Alkem Laboratories Market Cap at Rs 65,402.06 crore stands dramatically above the benchmark’s maximum listed value. That makes Alkem Laboratories Share Price News especially notable because the move is occurring in a stock far bigger than the sector snapshot’s typical company.

On valuation benchmarks, the Healthcare sector snapshot shows a P/E median of 26.2 and an average of 75.33 across 156 companies, with a wide range from 3.29 to 3299.57. The P/B median is 1.96 and the average is 2.65 across 195 companies, with values stretching from -10.01 to 16.63. Profitability benchmarks also vary: median ROE is 11.07 and average ROE is 15.46, while median ROCE is 13.35 and average ROCE is 17.73, both based on 195 companies.

Because company-specific P/E, P/B, ROE and ROCE for Alkem Laboratories are not part of the supplied data, the clean conclusion is not about cheapness or expensiveness. Instead, the sector data shows that Alkem Laboratories Share Price Today is moving within a Healthcare universe where valuation and return metrics span a very wide range. For investors, that means the stock’s scale and today’s price action matter immediately, while full relative valuation judgement requires the company-specific multiples alongside these benchmarks. Univest uses the sector snapshot here to frame relative context, not to stretch beyond the supplied facts.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,995.34	31.94	0.47	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,836.87	69.35	10.97	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,644.55	34.7	7.15	-2.6	16.92
Hikal Ltd.	HIKAL	2,619.52	0	2.24	15.22	16.15
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,605.37	45.02	1.73	-0.78	8.31

Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 65,402.06 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set gives a practical view of how Alkem Laboratories sits beside other listed Healthcare names on scale and, where available, on valuation and returns. Even before looking at P/E or profitability, market capitalisation is the clearest contrast. Alkem Laboratories stands at Rs 65,402.06 crore, while the listed peers in the dataset range from Rs 2214.91 crore for Venus Remedies Ltd. to Rs 2995.34 crore for Dishman Carbogen Amcis Ltd. That means Alkem Laboratories is much larger than every named peer in this comparison set.

Among peers with P/E data, Dishman Carbogen Amcis trades at 31.94, Beta Drugs at 69.35, Dr Agarwals Eye Hospital at 34.7, Ind-Swift Laboratories at 45.02, Sai Parenteral's at 174.73, Fredun Pharmaceuticals at 56.53 and Venus Remedies at 19.99. On P/B, peer values include 0.47 for Dishman Carbogen, 10.97 for Beta Drugs, 7.15 for Dr Agarwals, 2.24 for Hikal, 1.73 for Ind-Swift, 3.04 for Panacea Biotec, 3.19 for Sai Parenteral's, 1.96 for Solara Active Pharma Sciences, 8.44 for Fredun and 3.38 for Venus Remedies.

Profitability metrics in the peer pack also show dispersion. ROE ranges from -2.89 at Dishman Carbogen and -2.6 at Dr Agarwals to 18.65 at Beta Drugs and 17.23 at Solara. ROCE spans from -0.26 at Dishman Carbogen to 22.17 at Beta Drugs, with Hikal at 16.15 and Fredun at 13.15. This broad spread is useful for Alkem Laboratories Share Price News because it shows the Healthcare peer landscape is far from uniform; valuation and return profiles vary sharply even among companies in related pharmaceutical and healthcare segments.

The central peer takeaway is therefore about relative scale and market attention. A 3.76% move in Alkem Laboratories Share Price carries a different market weight than similar moves in companies with market caps of roughly Rs 2,200 crore to Rs 3,000 crore. In Market Movers coverage, that difference is often why large-cap share price declines attract closer tracking on platforms such as Univest.

Why Investors Are Watching Alkem Laboratories

Alkem Laboratories Share Price is being watched because today’s move combines a meaningful percentage decline with a large market capitalisation and a clear intraday reversal pattern. The stock opened at the day’s high and then weakened sharply, which immediately puts it on the radar in Top Losers Today screens and among Stocks Falling Today within the Healthcare segment.

• Verified price action: The stock fell Rs 203.75, or 3.76%, from Rs 5418.75 to Rs 5215.
• Intraday structure: The day open and high were both Rs 5554.9, while the low was Rs 5207.5, showing weak price action after the open.
• Scale: Market capitalisation is Rs 65,402.06 crore, making this a notable large-cap decline.
• Trading activity: Total volume reached 3,49,297 shares, with NSE volume at 3,40,421 and BSE volume at 8,876.
• Sector lens: The company sits in Healthcare, where the benchmark snapshot covers 196 companies with wide valuation and profitability ranges.

What investors may monitor next is straightforward: whether Alkem Laboratories Share Price stays close to the day low or stabilises above it, whether volume remains elevated across exchanges, and how the stock’s next move compares with broader sector behaviour. Univest is also useful here because it lets readers combine live Share Price tracking with structured sector and peer context instead of reading the decline in isolation.

About Alkem Laboratories

Alkem Laboratories Ltd. is classified in the supplied dataset under the Healthcare sector. The peer and benchmark context surrounding the stock is dominated by Pharmaceuticals & Drugs businesses, with one Hospital & Healthcare Services name also included in the comparison set. That places Alkem Laboratories Share Price within a part of the Indian Stock Market that is often tracked through sector breadth, peer valuation differences and company scale.

From the available classification data, Alkem Laboratories is best understood here as a large listed Healthcare company rather than through unsupported business-detail claims. Its market capitalisation of Rs 65,402.06 crore makes it substantially larger than the benchmark and peer set included in the current snapshot. That matters because large-cap Healthcare stocks can influence sector sentiment and appear prominently in NSE News and BSE News flows when they move sharply on a single day.

For readers following Alkem Laboratories Latest News and Alkem Laboratories Share News, the current dataset is most useful as a market update: it identifies the company, confirms its sector placement, and shows how today’s decline stands out against smaller listed Healthcare peers. Univest presents this company context as a base layer for understanding the stock move without stretching beyond verified data.

Track Alkem Laboratories Share Price on Univest

Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Readers who want to follow Alkem Laboratories Share Price beyond today’s decline can use Univest to track live share price movements, daily price action, market capitalisation trends and comparative sector context. Alkem Laboratories Share Price Today can be monitored alongside volume, exchange activity and broader stock analysis frameworks that help separate one-session volatility from longer market positioning.

Univest also helps users follow Alkem Laboratories Stock News, peer snapshots, shareholding pattern updates when available, 52-week levels, technical indicators when supplied, and key fundamental ratios as they are updated in verified datasets. For investors who prefer structured market insights over noise, that makes Univest a practical place to keep Alkem Laboratories Share Price on watch without turning a single session move into an unsupported conclusion.

Frequently Asked Questions

What is Alkem Laboratories Share Price Today?

Ans. Alkem Laboratories Share Price Today was Rs 5215 at the time of the supplied snapshot. The stock was down Rs 203.75 from the previous close of Rs 5418.75, reflecting a one-day decline of 3.76%.

Why is Alkem Laboratories Share Price falling today?

Ans. The supplied data confirms that Alkem Laboratories Share Price fell 3.76% today and stayed close to the session low. However, the dataset establishes the price event only and does not identify a company-specific catalyst for the decline.

How much did Alkem Laboratories stock fall today?

Ans. Alkem Laboratories stock fell by Rs 203.75 in today’s session. In percentage terms, the decline was 3.76%, taking the stock from the previous close of Rs 5418.75 to Rs 5215 at the snapshot time.

What were the day high and day low for Alkem Laboratories?

Ans. The stock’s day high was Rs 5554.9 and the day low was Rs 5207.5. Alkem Laboratories Share Price opened at Rs 5554.9 as well, showing that the session’s early level later gave way to selling pressure.

What does today’s price action indicate for Alkem Laboratories?

Ans. Today’s price action shows a weak intraday structure, because Alkem Laboratories opened at the day’s high of Rs 5554.9 and later traded near the low of Rs 5207.5. That pattern reflects persistent pressure after the opening trade.

What is the market capitalisation of Alkem Laboratories?

Ans. Alkem Laboratories had a market capitalisation of Rs 65,402.06 crore in the supplied data. That keeps the company in the Large Cap category, which makes a 3.76% single-day move notable in market-wide screens.

How much volume was traded in Alkem Laboratories today?

Ans. Total traded volume was 3,49,297 shares across exchanges. NSE volume stood at 3,40,421 shares, while BSE volume was 8,876 shares, showing that most of the day’s activity was concentrated on the NSE.

What was the turnover recorded on BSE for Alkem Laboratories?

Ans. The supplied dataset shows BSE turnover of Rs 4.63 crore for Alkem Laboratories. Along with BSE volume of 8,876 shares, that provides a verified exchange-level snapshot of trading activity during the price fall.

Which sector does Alkem Laboratories belong to?

Ans. Alkem Laboratories is classified in the Healthcare sector in the supplied data. The sector benchmark covers 196 companies, giving investors a useful comparison set for market capitalisation, valuation ranges and profitability ranges.

How does Alkem Laboratories compare with the supplied Healthcare peers on size?

Ans. Alkem Laboratories is far larger than the supplied peers on market capitalisation. Its market cap is Rs 65,402.06 crore, while the named peer set ranges from Rs 2214.91 crore to Rs 2995.34 crore.